X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES FDC LTD. JUBILANT LIFE SCIENCES/
FDC LTD.
 
P/E (TTM) x 17.1 22.2 76.8% View Chart
P/BV x 4.5 5.0 89.8% View Chart
Dividend Yield % 0.4 0.9 42.8%  

Financials

 JUBILANT LIFE SCIENCES   FDC LTD.
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
FDC LTD.
Mar-14
JUBILANT LIFE SCIENCES/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs187144 130.2%   
Low Rs6579 82.4%   
Sales per share (Unadj.) Rs364.347.6 766.0%  
Earnings per share (Unadj.) Rs6.87.6 90.0%  
Cash flow per share (Unadj.) Rs24.59.0 271.9%  
Dividends per share (Unadj.) Rs3.002.25 133.3%  
Dividend yield (eoy) %2.42.0 117.8%  
Book value per share (Unadj.) Rs164.947.5 346.9%  
Shares outstanding (eoy) m159.28177.83 89.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.32.3 14.8%   
Avg P/E ratio x18.414.6 125.8%  
P/CF ratio (eoy) x5.112.3 41.6%  
Price / Book Value ratio x0.82.3 32.6%  
Dividend payout %43.829.6 148.2%   
Avg Mkt Cap Rs m20,06119,784 101.4%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0521,221 905.5%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,0348,459 686.1%  
Other income Rs m191394 48.4%   
Total revenues Rs m58,2248,852 657.7%   
Gross profit Rs m5,7862,070 279.5%  
Depreciation Rs m2,812249 1,128.7%   
Interest Rs m3,23731 10,439.2%   
Profit before tax Rs m-722,184 -3.3%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696606 115.0%   
Profit after tax Rs m1,0901,353 80.6%  
Gross profit margin %10.024.5 40.7%  
Effective tax rate %-965.927.7 -3,482.9%   
Net profit margin %1.916.0 11.7%  
BALANCE SHEET DATA
Current assets Rs m29,2804,355 672.3%   
Current liabilities Rs m38,9121,792 2,171.5%   
Net working cap to sales %-16.630.3 -54.8%  
Current ratio x0.82.4 31.0%  
Inventory Days Days8444 189.8%  
Debtors Days Days5125 205.5%  
Net fixed assets Rs m55,7123,025 1,841.7%   
Share capital Rs m155179 86.5%   
"Free" reserves Rs m20,9688,243 254.4%   
Net worth Rs m26,2658,453 310.7%   
Long term debt Rs m17,16911 160,456.1%   
Total assets Rs m88,60610,557 839.3%  
Interest coverage x1.071.4 1.4%   
Debt to equity ratio x0.70 51,640.2%  
Sales to assets ratio x0.70.8 81.7%   
Return on assets %4.913.1 37.3%  
Return on equity %4.216.0 25.9%  
Return on capital %11.623.5 49.2%  
Exports to sales %37.813.3 284.0%   
Imports to sales %16.53.3 493.1%   
Exports (fob) Rs m21,9331,126 1,948.4%   
Imports (cif) Rs m9,567283 3,383.1%   
Fx inflow Rs m22,0041,146 1,919.9%   
Fx outflow Rs m11,749355 3,306.8%   
Net fx Rs m10,255791 1,296.8%   
CASH FLOW
From Operations Rs m8,0261,485 540.5%  
From Investments Rs m-1,744-620 281.5%  
From Financial Activity Rs m-4,447-753 591.0%  
Net Cashflow Rs m1,834113 1,626.3%  

Share Holding

Indian Promoters % 45.6 68.9 66.2%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 4.7 185.1%  
FIIs % 21.2 7.5 282.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 19.0 111.1%  
Shareholders   23,815 23,730 100.4%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  ORCHID PHARMA LTD  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY18); Net Profit Up 1.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 1.4% YoY). Sales on the other hand came in at Rs 23 bn (up 37.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

FDC LTD. Announces Quarterly Results (4QFY18); Net Profit Down 35.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, FDC LTD. has posted a net profit of Rs 315 m (down 35.8% YoY). Sales on the other hand came in at Rs 3 bn (up 5.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Sep 21, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - FRESENIUS KABI ONCO. COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS